Stanzololwas developed clinically by Winthrop Labs in 1962. It is a synthetic (man made) anabolic steroid and is a derivative of testosterone. It is an FDA approved drug for human use. Due to a C17 alpha-alkylation, it passes easily through liver after ingestion, as it does not breakup or dissolves in the body. It is also treated as a safer choice for both men and women athletes and bodybuilders. Its anabolic effects prevail over its androgenic effects. That makes it a safer choice.

Stanzolol has been clinically tried widely on animals and human beings. It has proven to be effective in treating in anemia and hereditary angioedema. It can be prescribed to improve muscle growth, red blood cell production, bone density increase and stimulation of appetite of weak body structure. It is an anabolic steroid generally used to help in increasing stamina and performance. It has been used extensively in U.S. horse racing.

Stanzolol is a derivative of dihydrotestosterone. It is a low androgenic steroid which has no tendency to aromatize. In a study, water retention has been reported in very few cases out of large number of people who used it. It can be stacked with other steroids or drugs. The best part is that gains in muscles sustain even when the drug intake is stopped. Stanzolol is quite effective in raising hemoglobin level in certain cases of aplastic anemia - congenital or idiopathic. It has a tendency of decreasing the frequency and severity of attacks in case of prophylaxis of hereditary angioedema.

Stanzolol is also used in the treatment of cases reporting decrease in fibrinolytic activities resulting from antithombin III shortage or excessive fibrinogen. Some of the conditions where it is quite effective are - cutaneous vasculitis, vasculitis of Behcet's disease, complications of deep vain thrombosis and scleroderma of Raynaud's disease. Stanzolol is also helpful in prevention of recurrent venous thrombosis connected to antithrombin III shortage. Patients prone to or with past record of thromboembolism for treatment of vascular irregularities with such types of reduced fibrinolytic activity.

Stanzolol is stacked with other testosterone derived anabolic steroids in case of bodybuilders. It is preferred over other derivatives by most of the steroid users as it is known to provide strength without unusual gain in weight. Since it does not have a tendency of excessive water retention and has a diuretic effect on the body, it is preferred for that reasons too. Stanzolol is usually administered to bodybuilders and athletes for the purpose of losing fat while sustaining lean body mass (LBM). To assist in preserving lean body mass along with metabolizing adipose tissues, it is generally used in Cutting Cycle.

In conclusion, Stanzolol, a derivative of dihydrotestosterone is a low androgenic steroid and is widely preferred due to its qualities and low side effects. As it has no water retention inducing tendency, people who take this drug have not reported any trouble of water retaining in body. As a result of that non retention of water in body, it does not drastically change the physical appearance of a person administering Stanzolol.